by Team Small News | Jun 25, 2025 | Biocon, Pharma
Biocon Biologics Ltd, a global biosimilars company, has partnered with the National Cancer Society of Malaysia (NCSM) to launch a Patient Assistance Programme (PAP) aimed at improving access to affordable, high-quality biosimilars for underserved cancer patients in... by Team Small News | Jun 10, 2025 | Biocon, Pharma
BioWISE, a pioneering initiative, aims to empower women entering the STEM workforce, particularly in the life sciences sector. This multi-dimensional platform seeks to bridge the gap in representation and opportunities for women in science, technology, engineering,... by Team Small News | Jun 5, 2025 | Biocon, Pharma
Biocon, a leading biopharmaceutical company, has announced the launch of its first vertically integrated GLP-1 product in India, a generic version of liraglutide. The company believes that GLP-1s will be the key drivers of its future growth, and this launch marks a... by Team Small News | May 28, 2025 | Biocon, Pharma
Kiran Mazumdar-Shaw, the executive chairperson of Biocon, took to social media to express her admiration for the Namma Metro, Bengaluru’s metro rail system. She tweeted about her experience of using the metro to commute, praising the service and thanking the... by Team Small News | May 27, 2025 | Biocon, Pharma
Biocon Biologics, a leading global biopharmaceutical company, has announced the extension of its insulin supply contract with the Ministry of Health in Malaysia. The contract, which was initially signed in 2019, has been extended for another three years, demonstrating... by Team Small News | May 23, 2025 | Biocon, Pharma
The Malaysian government has extended its insulin supply contract with India’s Biocon Biologics for an additional six months, from April 29 to October 28. The original 36-month contract, which began in 2022 and was set to expire in April 2025, was between the...